Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0036690 (
sepsis
)
59,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Leukocyte immunoglobulin (Ig)-like receptor B4 (
LILRB4
) is a member of leukocyte Ig-like receptors (LILRs), which associate with membrane adaptors to signal through multiple cytoplasmic immunoreceptor tyrosine-based inhibitory motifs (ITIMs). Under physiological conditions,
LILRB4
plays a very important role in the function of the immune system through its expression on various immune cells, such as T cells and plasma cells. Under pathological conditions,
LILRB4
affects the processes of various diseases, such as the transformation and infiltration of tumors and leukemias, through various signaling pathways. Differential expression of
LILRB4
is present in a variety of immune system diseases, such as Kawasaki disease, systemic lupus erythematosus (SLE), and
sepsis
. Recent studies have shown that
LILRB4
also plays a role in mental illness. The important role of
LILRB4
in the immune system and its differential expression in a variety of diseases make
LILRB4
a potential prophylactic and therapeutic target for a variety of diseases.
...
PMID:LILRB4, from the immune system to the disease target. 3277 91